NV
BIO icon

Nair Vinay’s Bio-Rad Laboratories Class A BIO Stock Holding History

Nair Vinay’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,153
Closed -$426K – 180
2015
Q1 		$426K Buy
3,153
+428
+16% +$53.1K 0.3% 94
2014
Q4 		$329K Buy
+2,725
New +$314K 0.4% 82

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nair Vinay's BIO Position: Q2 2015 in Review

Nair Vinay sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2015, closing a stake of 3,153 shares — an estimated $426K sold.

Nair Vinay first reported a position in BIO in Q4 2014 and held it in 2 quarters. The position peaked at $426K in Q1 2015. 225 funds tracked by Wall St. Rank hold BIO as of Q2 2015.

  • Nair Vinay reported no remaining Bio-Rad Laboratories Class A position as of Q2 2015 after selling out during the quarter.
  • Nair Vinay sold 3,153 Bio-Rad Laboratories Class A shares in Q2 2015, an estimated $426K.
  • Nair Vinay first reported a position in Bio-Rad Laboratories Class A in Q4 2014 and held it in 2 quarters.
  • Nair Vinay's Bio-Rad Laboratories Class A position peaked at $426K in Q1 2015.
  • 225 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.